GlassScriptPhysician profile
Christopher Edward Cook
NPI 1780999805
$9,060.67
in general payments reported to CMS, 2019-2025
27 companies · $1,873 in 2025
The $1,873 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $846 · 2020: $633 · 2021: $1,071 · 2022: $1,436 · 2023: $1,634 · 2024: $1,567 · 2025: $1,873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,966 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,966.49 |
| Education | $107.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,840.52 | 2019-2025 | Rinvoq, Skyrizi, Humira |
| Sun Pharmaceutical Industries INC. | $1,077.53 | 2020-2025 | Ilumya, Winlevi, Blu-U |
| Novartis Pharmaceuticals Corporation | $790.84 | 2019-2025 | |
| Ucb, INC. | $706.10 | 2019-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $635.03 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $593.82 | 2019-2025 | Dupixent, Libtayo |
| Genzyme Corporation | $553.20 | 2019-2025 | |
| Janssen Biotech, INC. | $548.78 | 2019-2025 | Tremfya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $547.95 | 2019-2024 | Arazlo, Cabtreo, Jublia |
| E.R. Squibb & Sons, L.L.C. | $293.78 | 2022-2025 | Sotyktu |
| Leo Pharma INC. | $284.73 | 2019-2025 | Adbry, Anzupgo |
| Astellas Pharma US INC | $181.98 | 2019 | |
| Arcutis Biotherapeutics, INC. | $171.73 | 2023-2025 | Zoryve |
| Pfizer INC. | $148.81 | 2019-2025 | |
| Incyte Corporation | $118.60 | 2023-2025 | Opzelura |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $85.24 | 2025 | Theragenesis Wound Matrix |
| Organon LLC | $76.68 | 2025 | Vtama |
| Galderma Laboratories, L.P. | $69.85 | 2019-2022 | |
| Dermavant Sciences, INC. | $63.19 | 2022-2024 | Vtama |
| Organogenesis INC. | $59.30 | 2019-2024 | Apligraf |
| Amgen INC. | $49.77 | 2020-2024 | Otezla |
| Almirall LLC | $44.76 | 2023 | Klisyri |
| Biofrontera INC. | $40.07 | 2022-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Dermira, INC. | $28.00 | 2020 | |
| Smith+Nephew, INC. | $22.77 | 2025 | Grafix Pl |
| Boston Scientific Corporation | $14.07 | 2021 | |
| Mayne Pharma Commercial LLC | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.